#云龙子艺术##Master yun art#
恭喜罗福腾教授(新跃大学)出了新书。
Professor Luo Fu Teng (Singapore University of Social Science) just published his new book.
感谢他送了我及陈丽湘博士一本。
Thank You for giving me and Dr Tan Lee Siang his new books.
我们三人在疫情之前一起共事了多年的教育与文化活动。(全国及国际中小学讲伟人故事活动及朝阳杯写作比赛)。
Three of us have done many years of educational and cultural activities together before the pandemic. (National and international story telling competitions and essay writing competitions )
罗教授当裁判,我赞助。陈博士出钱又出力当主办,最是劳苦功高。
Professor Luo as the judge, me as the donor. Dr Tan has put in the most effort as the organizer.
希望将来再有机会一起合作做些有意义的事。
I hope we have chance to do some meaningful things together again soon.
恭喜罗福腾教授(新跃大学)出了新书。
Professor Luo Fu Teng (Singapore University of Social Science) just published his new book.
感谢他送了我及陈丽湘博士一本。
Thank You for giving me and Dr Tan Lee Siang his new books.
我们三人在疫情之前一起共事了多年的教育与文化活动。(全国及国际中小学讲伟人故事活动及朝阳杯写作比赛)。
Three of us have done many years of educational and cultural activities together before the pandemic. (National and international story telling competitions and essay writing competitions )
罗教授当裁判,我赞助。陈博士出钱又出力当主办,最是劳苦功高。
Professor Luo as the judge, me as the donor. Dr Tan has put in the most effort as the organizer.
希望将来再有机会一起合作做些有意义的事。
I hope we have chance to do some meaningful things together again soon.
#前沿动态# 【[话筒]STTT:重磅!糖尿病迎来突破性药物,可恢复胰岛素产生!】
近日,澳大利亚莫纳什大学、香港中文大学的研究人员在 Nature 子刊" Signal Transduction and Targeted Therapy "(IF=38)期刊上发表了一篇题为" Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor "的研究论文。
该研究标志着 #糖尿病# 新疗法的重大突破,在对不能产生胰岛素的胰腺干细胞进行的实验中,发现了一种恢复胰腺细胞中胰岛素产生的新方法,将它们暴露于一种称为GSK126的药物中,胰腺干细胞被激活,并开始表达胰岛素。
近日,澳大利亚莫纳什大学、香港中文大学的研究人员在 Nature 子刊" Signal Transduction and Targeted Therapy "(IF=38)期刊上发表了一篇题为" Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor "的研究论文。
该研究标志着 #糖尿病# 新疗法的重大突破,在对不能产生胰岛素的胰腺干细胞进行的实验中,发现了一种恢复胰腺细胞中胰岛素产生的新方法,将它们暴露于一种称为GSK126的药物中,胰腺干细胞被激活,并开始表达胰岛素。
STTT:重磅!糖尿病迎来突破性药物,可恢复胰岛素产生!
近日,澳大利亚莫纳什大学、香港中文大学的研究人员在 Nature 子刊" Signal Transduction and Targeted Therapy "(IF=38)期刊上发表了一篇题为" Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor "的研究论文。
该研究标志着糖尿病新疗法的重大突破,在对不能产生胰岛素的胰腺干细胞进行的实验中,发现了一种恢复胰腺细胞中胰岛素产生的新方法,将它们暴露于一种称为GSK126的药物中,胰腺干细胞被激活,并开始表达胰岛素。
近日,澳大利亚莫纳什大学、香港中文大学的研究人员在 Nature 子刊" Signal Transduction and Targeted Therapy "(IF=38)期刊上发表了一篇题为" Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor "的研究论文。
该研究标志着糖尿病新疗法的重大突破,在对不能产生胰岛素的胰腺干细胞进行的实验中,发现了一种恢复胰腺细胞中胰岛素产生的新方法,将它们暴露于一种称为GSK126的药物中,胰腺干细胞被激活,并开始表达胰岛素。
✋热门推荐